These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9067762)

  • 1. Startle disease in an Italian family by mutation (K276E): The alpha-subunit of the inhibiting glycine receptor.
    Seri M; Bolino A; Galietta LJ; Lerone M; Silengo M; Romeo G
    Hum Mutat; 1997; 9(2):185-7. PubMed ID: 9067762
    [No Abstract]   [Full Text] [Related]  

  • 2. A novel mutation (Gln266-->His) in the alpha 1 subunit of the inhibitory glycine-receptor gene (GLRA1) in hereditary hyperekplexia.
    Milani N; Dalprá L; del Prete A; Zanini R; Larizza L
    Am J Hum Genet; 1996 Feb; 58(2):420-2. PubMed ID: 8571969
    [No Abstract]   [Full Text] [Related]  

  • 3. Analysis of GLRA1 in hereditary and sporadic hyperekplexia: a novel mutation in a family cosegregating for hyperekplexia and spastic paraparesis.
    Elmslie FV; Hutchings SM; Spencer V; Curtis A; Covanis T; Gardiner RM; Rees M
    J Med Genet; 1996 May; 33(5):435-6. PubMed ID: 8733061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Properties of human glycine receptors containing the hyperekplexia mutation alpha1(K276E), expressed in Xenopus oocytes.
    Lewis TM; Sivilotti LG; Colquhoun D; Gardiner RM; Schoepfer R; Rees M
    J Physiol; 1998 Feb; 507 ( Pt 1)(Pt 1):25-40. PubMed ID: 9490812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The genetics of hyperekplexia: more than startle!
    Harvey RJ; Topf M; Harvey K; Rees MI
    Trends Genet; 2008 Sep; 24(9):439-47. PubMed ID: 18707791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel missense mutations in the glycine receptor β subunit gene (GLRB) in startle disease.
    James VM; Bode A; Chung SK; Gill JL; Nielsen M; Cowan FM; Vujic M; Thomas RH; Rees MI; Harvey K; Keramidas A; Topf M; Ginjaar I; Lynch JW; Harvey RJ
    Neurobiol Dis; 2013 Apr; 52():137-49. PubMed ID: 23238346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the alpha 1 subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexia.
    Shiang R; Ryan SG; Zhu YZ; Hahn AF; O'Connell P; Wasmuth JJ
    Nat Genet; 1993 Dec; 5(4):351-8. PubMed ID: 8298642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperekplexia: abnormal startle response due to glycine receptor mutations.
    Andrew M; Owen MJ
    Br J Psychiatry; 1997 Feb; 170():106-8. PubMed ID: 9093496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a de novo Lys304Gln mutation in the glycine receptor alpha-1 subunit gene in a Korean infant with hyperekplexia.
    Kang HC; Jeong You S; Jae Chey M; Sam Baik J; Kim JW; Ki CS
    Mov Disord; 2008 Mar; 23(4):610-3. PubMed ID: 18175347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An additional family with Startle disease and a G1192A mutation at the alpha 1 subunit of the inhibitory glycine receptor gene.
    Schorderet DF; Pescia G; Bernasconi A; Regli F
    Hum Mol Genet; 1994 Jul; 3(7):1201. PubMed ID: 7981700
    [No Abstract]   [Full Text] [Related]  

  • 11. Hyperekplexia: a treatable neurogenetic disease.
    Zhou L; Chillag KL; Nigro MA
    Brain Dev; 2002 Oct; 24(7):669-74. PubMed ID: 12427512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiological mechanisms of dominant and recessive GLRA1 mutations in hyperekplexia.
    Chung SK; Vanbellinghen JF; Mullins JG; Robinson A; Hantke J; Hammond CL; Gilbert DF; Freilinger M; Ryan M; Kruer MC; Masri A; Gurses C; Ferrie C; Harvey K; Shiang R; Christodoulou J; Andermann F; Andermann E; Thomas RH; Harvey RJ; Lynch JW; Rees MI
    J Neurosci; 2010 Jul; 30(28):9612-20. PubMed ID: 20631190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Startle disease].
    Okino S; Yamada M
    Ryoikibetsu Shokogun Shirizu; 2002; (37 Pt 6):403-5. PubMed ID: 12483911
    [No Abstract]   [Full Text] [Related]  

  • 14. Hyperekplexia in the first year of life.
    Koning-Tijssen MA; Brouwer OF
    Mov Disord; 2000 Nov; 15(6):1293-6. PubMed ID: 11104232
    [No Abstract]   [Full Text] [Related]  

  • 15. A novel GLRA1 mutation associated with an atypical hyperekplexia phenotype.
    Gregory ML; Guzauskas GF; Edgar TS; Clarkson KB; Srivastava AK; Holden KR
    J Child Neurol; 2008 Dec; 23(12):1433-8. PubMed ID: 19073849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two Japanese families with hyperekplexia who have a Arg271Gln mutation in the glycine receptor alpha 1 subunit gene.
    Kimura M; Taketani T; Horie A; Isumi H; Sejima H; Yamaguchi S
    Brain Dev; 2006 May; 28(4):228-31. PubMed ID: 16478653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperekplexia and the alpha1 subunit glycine receptor gene (GLRA1).
    Turecki G; Grand'Maison F; Lemieux B; Rouleau G
    Arch Neurol; 1996 Sep; 53(9):836-7. PubMed ID: 8815845
    [No Abstract]   [Full Text] [Related]  

  • 18. Novel mutation of GLRA1 in Omani families with hyperekplexia and mild mental retardation.
    Al-Futaisi AM; Al-Kindi MN; Al-Mawali AM; Koul RL; Al-Adawi S; Al-Yahyaee SA
    Pediatr Neurol; 2012 Feb; 46(2):89-93. PubMed ID: 22264702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in the glycine receptor alpha1 subunit (GLRA1) gene in hereditary hyperekplexia pedigrees: evidence for non-penetrance of mutation Y279C.
    Kwok JB; Raskin S; Morgan G; Antoniuk SA; Bruk I; Schofield PR
    J Med Genet; 2001 Jun; 38(6):E17. PubMed ID: 11389164
    [No Abstract]   [Full Text] [Related]  

  • 20. Compound heterozygosity and nonsense mutations in the alpha(1)-subunit of the inhibitory glycine receptor in hyperekplexia.
    Rees MI; Lewis TM; Vafa B; Ferrie C; Corry P; Muntoni F; Jungbluth H; Stephenson JB; Kerr M; Snell RG; Schofield PR; Owen MJ
    Hum Genet; 2001 Sep; 109(3):267-70. PubMed ID: 11702206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.